Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Allcyte logo — Allcyte tests drugs in human tissue for personalized medicin...

Allcyte

Allcyte tests drugs in human tissue for personalized medicine and helps focus drug development efforts.

Founded 2017 Austria Austria 2-10 employees Grant Total: $6.00M Biotechnology, Health Care +2

General Information

Company Name Allcyte
Founded Year 2017
Location Austria Austria
Employees 2-10
Industries Biotechnology, Health Care, Pharmaceutical +1
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Allcyte. To contact Allcyte, visit allcyte.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Allcyte compare?

A PDF of Allcyte and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Allcyte soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Allcyte

Allcyte is a biotechnology startup based in Austria that specializes in conducting functional drug testing on human tissue. Established in 2017, the company's mission is to revolutionize personalized medicine for cancer patients and healthcare providers. Leveraging its cutting-edge Pharmacoscopy high-content imaging platform and AI-driven image analysis pipelines, Allcyte assists pharmaceutical firms in focusing their drug development efforts on the most suitable molecules and indications. The startup's approach enables them to measure individual cell characteristics directly in unaltered patient samples, with minimal modifications and sample requirements. Notably, EIT Health recently provided grant investment to support Allcyte's groundbreaking work on 09 July 2020. By enabling the testing of drugs in human tissue, Allcyte is playing a crucial role in driving the advancement of personalized medicine and refining the drug development landscape within the biotechnology and pharmaceutical industries.

Business keywords: personalized medicine, drug testing, cancer, Pharmacoscopy, high-content imaging, AI-assisted, primary human material, pharmaceutical, image-based measurement, statistics, biomedical decisions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
EIT Health
09 Jul 2020
Seed Round $6.00M 5
Air Street Capital PUSH Ventures 42CAP
Air Street Capital, PUSH Ventures +3
01 Jul 2020

Allcyte Alternatives & Competitors

View All Alternatives
Allcyte vs
Oncomedics
Oncomedics

1 patient - 1 tumour - 1 Oncogramme® - 1 treatment

Angel
11 employees
Biotechnology, Pharmaceutical
Allcyte vs
Genus Oncology LLC
Genus Oncology LLC

Discovering New Frontiers in Anti-Cancer Therapeutics: Targeting MUC1 for a Healthier Tomorrow

Series A
3 employees
Biotechnology, Health Care
Allcyte vs
Emulate, Inc.
Emulate, Inc. United States

Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of human biol...

Series F
71 employees
Biotechnology, Health Care
View all alternatives

FAQ About Allcyte

Allcyte tests drugs in human tissue for personalized medicine and helps focus drug development efforts.
Allcyte was founded in 2017.
Allcyte is headquartered in Austria.
Allcyte operates in Biotechnology, Health Care, Pharmaceutical and Machine Learning. Its work centres on personalized medicine, drug testing, cancer and Pharmacoscopy.
Allcyte has approximately 2-10 employees.
Allcyte has completed 2 funding rounds, raising a total of $6.00M. The latest funding stage is Grant.
Top alternatives and competitors to Allcyte include Oncomedics, Genus Oncology LLC, Emulate, Inc., OrganOmics, Phoenix Molecular Designs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Allcyte and Oncomedics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Allcyte, https://bouncewatch.com/company/allcyte, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout